Alopecia Market

DelveInsight's "Alopecia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Alopecia, historical and forecasted epidemiology as well as the Alopecia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Alopecia market report provides current treatment practices, emerging drugs, Alopecia market share of the individual therapies, current and forecasted Alopecia market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Alopecia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Alopecia market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

 

Study Period: 2019-2032

Alopecia Disease Understanding and Treatment Algorithm

Alopecia refers to temporary or permanent hair loss from the scalp or entire body as a result of genes, changes in hormones, medical conditions or aging, generally affecting men. Signs of Alopecia may include: gradual thinning of hair on top of head, circular or patchy bald spots on scalp, beard or eyebrows, sudden hair fall, full body hair loss and patches of stalling that spread over the scalp. 

Different types of alopecia are as follows:

  • Alopecia areata 
  • Androgenic alopecia 
  • Telogen effluvium
  • Anagen effluvium
  • Traumatic alopecia
  • Tinea capitis 
  • Alopecia mucinosa 
  • Alopecia neoplastica

 

The treatment for alopecia depends on the cause behind the condition. Sometimes the hair loss may get better on its own and no treatment is needed. However in case of severe hair loss, medicines and hair transplant surgery are the available options. 

 

Alopecia Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Alopecia.

 

Alopecia Treatment

It covers the details of conventional and current medical therapies available in the Alopecia market for the treatment of the condition. It also provides Alopecia treatment algorithms and guidelines in the United States, Europe, and Japan.

Alopecia Epidemiology 

The Alopecia epidemiology section provides insights about the historical and current Alopecia patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Alopecia market report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 

 

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Alopecia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

 

  • The epidemiology of alopecia is variable as it depends on the cause of alopecia and the type. 
  • Alopecia areata, has a prevalence of 0.2 percent and it may affect any one  irrespective of their race, sex or age group.
  • The most common form of alopecia is androgenetic alopecia that's 50% of men and 15% of women. It affects white race and postmenopausal women more.
  • Telogen effluvium tends to affect women more than men. 
  • In tinea capitis, the incidence is much higher in the pediatric age group and is more common in dark-skin individuals with no sexual predilection.
  • Anagen effluvium is common in cancer patients being treated with chemotherapeutic agents.

 

Country Wise- Alopecia Epidemiology

The epidemiology segment also provides the Alopecia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Alopecia Drug Chapters

The drug chapter segment of the Alopecia report encloses the detailed analysis of Alopecia marketed drugs and late-stage (Phase-III and Phase-II) Alopecia pipeline drugs. It also helps to understand the Alopecia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

 

Alopecia Marketed Drugs

The report provides the details of the marketed products/off-label treatments available for Alopecia treatment.

 

Alopecia Companies

  • Stiefel
  • GlaxoSmithKline
  • Eli Lilly and Company
  • Incyte Corporation
  • Energenesis Biomedical Co., Ltd.
  • And, Many More

 

Alopecia Drugs

  • Dutasteride
  • Baricitinib
  • ENERGI-F701
  • Regaine
  • And, Many More

Alopecia Market Outlook

The Alopecia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Alopecia market trends by analyzing the impact of current Alopecia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Alopecia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Alopecia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Alopecia market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Key Findings

This section includes a glimpse of the Alopecia market in 7MM.

 

The United States Alopecia Market Outlook

This section provides the total Alopecia market size and market size by therapies in the United States.

 

EU-5 Countries: Alopecia Market Outlook

The total Alopecia market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

 

Japan Alopecia Market Outlook

The total Alopecia market size and market size by therapies in Japan is also mentioned.

Alopecia Drugs Uptake

This section focuses on the rate of uptake of the potential Alopecia drugs recently launched in the Alopecia market or expected to get launched in the market during the study period 2019-2032. The analysis covers Alopecia market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Alopecia Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allow the comparison of the drugs on the basis of Alopecia market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Alopecia Pipeline Development Activities

The Alopecia report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Alopecia key players involved in developing targeted therapeutics.

 

Pipeline Development Activities

The Alopecia report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Alopecia emerging therapies.

Reimbursement Scenario in Alopecia

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current Alopecia market trends, we take KOLs and SMEs ' opinion working in the Alopecia domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Alopecia market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Alopecia Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Alopecia Report

  • The report covers the descriptive overview of Alopecia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Alopecia epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Alopecia is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Alopecia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Alopecia market

Alopecia Report Highlights

  • In the coming years, the Alopecia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Alopecia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
  • Major players are involved in developing therapies for Alopecia. The launch of emerging therapies will significantly impact the Alopecia market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Alopecia
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Alopecia Report Insights

  • Alopecia Patient Population
  • Alopecia Therapeutic Approaches
  • Alopecia Pipeline Analysis
  • Alopecia Market Size
  • Alopecia Maarket Trends
  • Alopecia Market Opportunities
  • Impact of upcoming Alopecia Therapies

Alopecia Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Alopecia Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Alopecia Market
  • Alopecia Drugs Uptake

Alopecia Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Alopecia Pipeline Product Profiles
  • Alopecia Market Attractiveness
  • Alopecia Market Drivers
  • Alopecia Market Barriers

Key Questions

Alopecia Market Insights:

  • What was the Alopecia drug class share (%) distribution in 2019 and how it would look like in 2032?
  • What would be the Alopecia total market size as well as market size by therapies across the 7MM during the forecast period (2019-2032)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Alopecia market size during the forecast period (2019-2032)?
  • At what CAGR, the Alopecia market is expected to grow by 7MM during the forecast period (2019-2032)?
  • What would be the Alopecia market outlook across the 7MM during the forecast period (2019-2032)?
  • What would be the Alopecia market growth till 2032, and what will be the resultant market Size in the year 2032?
  • How would the unmet needs affect the market dynamics and subsequent analysis of the associated trends?

Alopecia Epidemiology Insights:

  • What are the disease risk, burden, and regional/ethnic differences of the Alopecia?
  • What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What is the historical Alopecia patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Alopecia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Alopecia?
  • Out of all 7MM countries, which country would have the highest prevalent population of Alopecia during the forecast period (2019-2032)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Alopecia treatment in addition to the approved therapies?
  • What are the current treatment guidelines for the treatment of Alopecia in the USA, Europe, and Japan?
  • What are the Alopecia marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Alopecia?
  • How many therapies are in-development by each company for Alopecia treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Alopecia treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Alopecia therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Alopecia and their status?
  • What are the current challenges faced in drug development?
  • What are the key designations that have been granted for the emerging therapies for Alopecia?
  • What are the global historical and forecasted market of Alopecia?

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Alopecia market
  • To understand the future market competition in the Alopecia market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Alopecia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Alopecia market
  • To understand the future market competition in the Alopecia market

1. Key Insights

2. Executive Summary of Alopecia

3. Competitive Intelligence Analysis for Alopecia

4. Alopecia: Market Overview at a Glance

4.1. Alopecia Total Market Share (%) Distribution in 2019

4.2. Alopecia Total Market Share (%) Distribution in 2032

5. Alopecia: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms

5.3. Pathophysiology

5.4. Risk Factors

5.5. Diagnosis

6. Patient Journey

7. Alopecia Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Alopecia Epidemiology Scenario in the 7MM (2019-2032)

7.4. United States Epidemiology

7.4.1. Alopecia Epidemiology Scenario in the United States (2019-2032)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Alopecia Epidemiology Scenario in Germany (2019-2032)

7.5.2. France Epidemiology

7.5.2.1. Alopecia Epidemiology Scenario in France (2019-2032)

7.5.3. Italy Epidemiology

7.5.3.1. Alopecia Epidemiology Scenario in Italy (2019-2032)

7.5.4. Spain Epidemiology

7.5.4.1. Alopecia Epidemiology Scenario in Spain (2019-2032)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Alopecia Epidemiology Scenario in the United Kingdom (2019-2032)

7.5.6. Japan Epidemiology

7.5.6.1. Alopecia Epidemiology Scenario in Japan (2019-2032)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Alopecia Treatment and Management

8.2. Alopecia Treatment Algorithm

9. Alopecia Unmet Needs

10. Key Endpoints of Alopecia Treatment

11. Alopecia Marketed Products

11.1. List of Alopecia Marketed Drugs in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Alopecia Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Alopecia: Seven Major Market Analysis

13.1. Key Findings

13.2. Alopecia Market Size in 7MM

13.3. Alopecia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Alopecia Market Outlook

15.1. United States: Alopecia Market Size

15.1.1. Alopecia Total Market Size in the United States

15.1.2. Alopecia Market Size by Therapies in the United States

15.2. EU-5 countries: Alopecia Market Size and Outlook

15.3. Germany Alopecia Market Size

15.3.1. Alopecia Total Market Size in Germany

15.3.2. Alopecia Market Size by Therapies in Germany

15.4. France Alopecia Market Size

15.4.1. Alopecia Total Market Size in France

15.4.2. Alopecia Market Size by Therapies in France

15.5. Italy Alopecia Market Size

15.5.1. Alopecia Total Market Size in Italy

15.5.2. Alopecia Market Size by Therapies in Italy

15.6. Spain Alopecia Market Size

15.6.1. Alopecia Total Market Size in Spain

15.6.2. Alopecia Market Size by Therapies in Spain

15.7. United Kingdom Alopecia Market Size

15.7.1. Alopecia Total Market Size in the United Kingdom

15.7.2. Alopecia Market Size by Therapies in the United Kingdom

15.8. Japan Alopecia Market Outlook

15.8.1. Japan Alopecia Market Size

15.8.2. Alopecia Total Market Size in Japan

15.8.3. Alopecia Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Alopecia

17. KOL Views

18. Alopecia Market Drivers

19. Alopecia Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary.

List of Table

Table 1: 7MM Alopecia Epidemiology (2019-2032)

Table 2: 7MM Alopecia Diagnosed and Treatable Cases (2019-2032)

Table 3: Alopecia Epidemiology in the United States (2019-2032)

Table 4: Alopecia Diagnosed and Treatable Cases in the United States (2019-2032)

Table 5: Alopecia Epidemiology in Germany (2019-2032)

Table 6: Alopecia Diagnosed and Treatable Cases in Germany (2019-2032)

Table 7: Alopecia Epidemiology in France (2019-2032)

Table 8: Alopecia Diagnosed and Treatable Cases in France (2019-2032)

Table 9: Alopecia Epidemiology in Italy (2019-2032)

Table 10: Alopecia Diagnosed and Treatable Cases in Italy (2019-2032)

Table 11: Alopecia Epidemiology in Spain (2019-2032)

Table 12: Alopecia Diagnosed and Treatable Cases in Spain (2019-2032)

Table 13: Alopecia Epidemiology in the UK (2019-2032)

Table 14: Alopecia Diagnosed and Treatable Cases in the UK (2019-2032)

Table 15: Alopecia Epidemiology in Japan (2019-2032)

Table 16: Alopecia Diagnosed and Treatable Cases in Japan (2019-2032)

Table 17: Drug Name, Clinical Trials by Recruitment status

Table 18: Drug Name, Clinical Trials by Zone

Table 19: Total Seven Major Market Size in USD, Million (2019-2032)

Table 20: Region-wise Market Size in USD, Million (2019-2032)

Table 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)

Table 22: United States Market Size in USD, Million (2019-2032)

Table 23: United States Market Size by Therapy in USD, Million (2019-2032)

Table 24: Germany Market Size in USD, Million (2019-2032)

Table 25: Germany Market Size by Therapy in USD, Million (2019-2032)

Table 26: France Market Size in USD, Million (2019-2032)

Table 27: France Market Size by Therapy in USD, Million (2019-2032)

Table 28: Italy Market Size in USD, Million (2019-2032)

Table 29: Italy Market Size by Therapy in USD, Million (2019-2032)

Table 30: Spain Market Size in USD, Million (2019-2032)

Table 31: Spain Market Size by Therapy in USD, Million (2019-2032)

Table 32: United Kingdom Market Size in USD, Million (2019-2032)

Table 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)

Table 34: Japan Market Size in USD, Million (2019-2032)

Table 35: Japan Market Size by Therapy in USD, Million (2019-2032)

*The list of tables is not exhaustive; the final content may vary

List of Figures

Figure 1: 7MM Alopecia Epidemiology (2019-2032)

Figure 2: 7MM Alopecia Diagnosed and Treatable Cases (2019-2032)

Figure 3: Alopecia Epidemiology in the United States (2019-2032)

Figure 4: Alopecia Diagnosed and Treatable Cases in the United States (2019-2032)

Figure 5: Alopecia Epidemiology in Germany (2019-2032)

Figure 6: Alopecia Diagnosed and Treatable Cases in Germany (2019-2032)

Figure 7: Alopecia Epidemiology in France (2019-2032)

Figure 8: Alopecia Diagnosed and Treatable Cases in France (2019-2032)

Figure 9: Alopecia Epidemiology in Italy (2019-2032)

Figure 10: Alopecia Diagnosed and Treatable Cases in Italy (2019-2032)

Figure 11: Alopecia Epidemiology in Spain (2019-2032)

Figure 12: Alopecia Diagnosed and Treatable Cases in Spain (2019-2032)

Figure 13: Alopecia Epidemiology in the UK (2019-2032)

Figure 14: Alopecia Diagnosed and Treatable Cases in the UK (2019-2032)

Figure 15: Alopecia Epidemiology in Japan (2019-2032)

Figure 16: Alopecia Diagnosed and Treatable Cases in Japan (2019-2032)

Figure 17: Drug Name, Clinical Trials by Recruitment status

Figure 18: Drug Name, Clinical Trials by Zone

Figure 19: Total Seven Major Market Size in USD, Million (2019-2032)

Figure 20: Region-wise Market Size in USD, Million (2019-2032)

Figure 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)

Figure 22: United States Market Size in USD, Million (2019-2032)

Figure 23: United States Market Size by Therapy in USD, Million (2019-2032)

Figure 24: Germany Market Size in USD, Million (2019-2032)

Figure 25: Germany Market Size by Therapy in USD, Million (2019-2032)

Figure 26: France Market Size in USD, Million (2019-2032)

Figure 27: France Market Size by Therapy in USD, Million (2019-2032)

Figure 28: Italy Market Size in USD, Million (2019-2032)

Figure 29: Italy Market Size by Therapy in USD, Million (2019-2032)

Figure 30: Spain Market Size in USD, Million (2019-2032)

Figure 31: Spain Market Size by Therapy in USD, Million (2019-2032)

Figure 32: United Kingdom Market Size in USD, Million (2019-2032)

Figure 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)

Figure 34: Japan Market Size in USD, Million (2019-2032)

Figure 35: Japan Market Size by Therapy in USD, Million (2019-2032)

*The list of figures is not exhaustive; the final content may vary

Alopecia Companies

  • Stiefel
  • GlaxoSmithKline
  • Eli Lilly and Company
  • Incyte Corporation
  • Energenesis Biomedical Co., Ltd.
  • And, Many More

Forward to Friend

Need A Quote